Serum levels of soluble CD26 in patients with scleroderma

Journal of Dermatological Science

Volumn 52, Issue 1, 2008, Pages 66-69

  Tamaki, Zenshiro ^a   Kubo, Masahide ^a   Yazawa, Norihito ^a   Mimura, Yoshihiro ^a   Ashida, Ryuuichi ^a   Tomita, Manabu ^a   Tada, Yayoi ^a   Kawashima, Tomohiko ^a   Tamaki, Kunihiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV;

ADOLESCENT; ADULT; AGED; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LETTER; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESPIRATORY FUNCTION; SCHOOL CHILD; SERUM; SKINFOLD THICKNESS; SYSTEMIC SCLEROSIS;

EID: 49849099246     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2008.05.004     Document Type: Letter

References (10)

1. LeRoy E.C. A brief overview of the pathogenesis of scleroderma (systemic sclerosis). Ann Rheum Dis 51 (1992) 286-288
2. Hegen M., Niedobitek G., Klein C.E., et al. The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity. J Immunol 144 (1990) 2908-2914
3. Hanski C., Huhle T., Gossrau R., and Reutter W. Direct evidence for the binding of rat liver DPP IV to collagen in vitro. Exp Cell Res 178 (1988) 64-72
4. Bermpohl F., Löster K., Reutter W., and Baum O. Rat dipeptidyl peptidase IV (DPPIV) exhibits endopeptidase activity with specificity for denaturated fibrillar collagens. FEBS Lett 428 (1988) 152-156
5. Kobayashi H., Hosono O., Mimori T., et al. Reduction of serum soluble CD26/dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus. J Rheumatol 29 (2002) 1858-1866
6. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic, Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23 (1980) 581-590
7. LeRoy E.C., Krieg T., Black C., et al. Scleroderma (systemic sclerosis): classification, subset, and pathogenesis. J Rheumatol 15 (1988) 202-205
8. Yazawa N., Kikuchi K., Ihn H., et al. Serum levels of tissue inhibitor of metalloproteinases 2 in patients with systemic sclerosis. J Am Acad Dermatol 42 (2000) 70-75
9. Busso N., Wagtmann N., Herling C., et al. Circulating CD26 is negatively associated with inflammation in human and experimental arthritis. Am J Pathol 166 (2005) 433-442
10. Bou-Gharios G., Osman J., Atherton A., et al. Expression of ectopeptidases in scleroderma. Ann Rheum Dis 54 (1995) 111-116